In this database, useful information about carbohydrate antigens, ie, glycoepitopes, and antibodies is organized as a compact encyclopedia.
Source | Last Updated |
---|---|
GlycoEpitope | November 18, 2015 |
Epitope ID | Epitope Name ▲ | Epitope Sequence |
---|---|---|
EP0512 | 1-3,1-4 beta Glucan | Partial structure of 1-3,1-4 beta Glucan : ---Glc(b1-4)Glc(b1-4)Glc(b1-3)Glc(b1-4)Glc(b1-4)Glc(b1)--- |
EP0507 | 1-6 beta Galactan | -[Gal(b1-6)]n- |
EP0323 | 2-3 Sialyl-Lacto-N-Tetraose | Neu5Ac(a2-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc-R |
EP0076 | 2-3 Sialylparagloboside | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
EP0213 | 2-6 Sialyl i-Lewis x | Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0353 | 2-6 Sialyl-LacNAc-Gal | Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-)-R |
EP0077 | 2-6 Sialylparagloboside | Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer |
EP0115 | 2-9,2-6 Disialyllactosylceramide | Neu5Ac(a2-9)Neu5Ac(a2-6)Gal(b1-4)Glc(b1-1)Cer |
EP0009 | 3'-Sulfo Lewis a | HSO3(-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0013 | 3'-Sulfo Lewis x | HSO3(-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0014 | 6'-Sulfo Sialyl Lewis x | Neu5Ac(a2-3)[HSO3(-6)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0016 | 6,6'- Disulfo Sialyl Lewis x | Neu5Ac(a2-3)[HSO3(-6)]Gal(b1-4)[Fuc(a1-3)][HSO3(-6)]GlcNAc(b1-)-R |
EP0144 | 6,6'-Sulfo LacNAc | HSO3(-6)Gal(b1-4)[HSO3(-6)]GlcNAc(b1-)-R |
EP0145 | 6,6,6'-Sulfo LacNAc | HSO3(-6)Gal(b1-4)[HSO3(-6)]GlcNAc(b1-3)[HSO3(-6)]Gal(b1-)-R |
EP0141 | 6-Sulfo LacNAc | Gal(b1-4)[HSO3(-6)]GlcNAc(b1-)-R |
EP0142 | 6-Sulfo Lewis x | Gal(b1-4)[Fuc(a1-3)][HSO3(-6)]GlcNAc(b1-)-R |
EP0064 | 9-O-Acetyl GD3 | Neu5Ac9Ac(a2-8)Neu5Ac(a2-3)Gal(b1-4)Glc(b1-1)Cer |
EP0065 | 9-O-Acetyl Sialic Acid | Neu5Ac9Ac(a2-)-R |
EP0088 | Acharan Sulfate | -{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- |
EP0200 | Alpha-Galactosyl Epitope | Gal(a1-3)Gal(b1-4)GlcNAc-R |
EP0508 | Arabinan | Partial structure of Arabinan : ---Ara(a1-5)Ara(a1-5)[Ara(a1-3])Ara(a1-5)Ara(a1-5)[Ara(a1-2)]Ara(a1-5)Ara(a1-5)--- |
EP0503 | Arabinogalactan Type I | Partial structure of Arabinogalactan Type l : ---Gal(b1-4)Gal(b1-4)[Ara(a1-5)Ara(a1-3)]Gal(b1-4)[Ara(a1-3)]Gal(b1-4)Gal(b1-4)Gal(b1-4)--- |
EP0504 | Arabinogalactan Type ll | Partial structure of Arabinogalactan Type ll : ---Gal(b1-3)[Ara(b1-6)]Gal(b1-3)[Ara(b1-3)Ara(b1-6)]Gal(b1-3)[Gal(b1-6)Gal(b1-6)]Gal(b1-3)[Gal(b1-6)Gal(b1-6)]Gal(b1-3)Gal(b1-3)--- |
EP0047 | Asialo GM1 | Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0068 | Bata Galactose | Gal(b1-)-R-Cer |
EP0255 | Blood Group A Trisaccharide | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-)-R |
EP0256 | Blood Group A Type 1 | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-)-R |
EP0260 | Blood Group A Type 1 (difucosyl) | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0257 | Blood Group A Type 2 | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-)-R |
EP0261 | Blood Group A Type 2 (difucosyl) | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0258 | Blood Group A Type 3 | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)GalNAc(a1-)-R |
EP0259 | Blood Group A Type 4 | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)GalNAc(b1-)-R |
EP0262 | Blood Group B Type 2 | Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-)-R |
EP0250 | Blood Group H Disaccharide | Fuc(a1-2)Gal(b1-)-R |
EP0251 | Blood Group H Type 1 | Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R |
EP0252 | Blood Group H Type 2 | Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R |
EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R |
EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
EP0032 | C-Series Gangliosides Oligosaccharide / Hemato- or Ganglio-Type | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)Gal-R |
EP0033 | C-Series Gangliosides Oligosaccharide / Gangliotetraosyl Core Structure | R-Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
EP0084 | Chindroitin Sulfate D Unit | -{[HSO3(-2)]GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
EP0081 | Chondroitin | -[GlcA(b1-3)GalNAc(b1-4)]n- |
EP0082 | Chondroitin-4-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
EP0083 | Chondroitin-6-Sulfate | -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
EP0017 | Cyclic Sialyl 6-Sulfo Lewis x | cyclicNeu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)][HSO3(-6)]GlcNAc-R |
EP0087 | Delta-Heparan Sulfate | unsaturated uronic acid |
EP0090 | Dimeric Lewis a | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
EP0093 | Dimeric Lewis x | Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
EP0098 | Disialyl Gb5 | Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer |
EP0095 | Disialyl I | Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-6)[Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-)-R |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024